bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.04.22.649958

FMed-Diffusion Federated Learning on Medical Image Diffusion

Abstract

Medical data is not available for public access due to privacy concerns of the patients and the stakeholders trustworthiness. However, Artificial Intelligence, especially all deeplearning models, is data hungry and fails to produce clinically relevant results without much data. Moreover, augmentation strategies are deployed to overcome the less data hurdle. The promising future in this direction is generative AI augmented data. The chatGPT and DALLE2 have become commercial products leveraging the generative AI in Natural Language Processing and Computer Vision. The diffusion models have started giving many promising results in the generative AI in computer vision. And in medical imaging, they can potentially create synthetic data to augment the scarce dataset. Diffusion models coupled with federated learning can create synthetic data on a large scale without the need to violate data privacy. This synthetic dataset could be used for further training of deeplearning models without the issues of patients identity theft from reverse engineering data. A Federated Learning paradigm of diffusion models has been proposed to overcome this hurdle and its related challenges. Our work focuses on diffusion models in federated learning settings. We named our novel model FMedDiffusion or Federated Learning on Medical Image Diffusion. We trained our model under distributed federated settings imitating real world clinical settings. We have achieved impressive results over three medical image datasets, APTOS 2019 Blindness Detection, Retinal OCT Detection, and COVID CT Detection in the federated setting on par with the traditional training. Our model FMedDiffusion has achieved an FID score of 7.1821 on the APTOS 2019 Blindness Detection dataset, an FID score of 8.8154 on the Retinal OCT Detection dataset and an FID score of 7.4486 on the COVID CT Detection dataset.reverse engineering data. A Federated Learning paradigm of diffusion models has been proposed to overcome this hurdle and its related challenges. Our work focuses on diffusion models in federated learning settings. We named our novel model FMedDiffusion or Federated Learning on Medical Image Diffusion. We trained our model under distributed federated settings imitating real world clinical settings. We have achieved impressive results over three medical image datasets, APTOS 2019 Blindness Detection, Retinal OCT Detection, and COVID CT Detection in the federated setting on par with the traditional training. Our model FMedDiffusion has achieved an FID score of 7.1821 on the APTOS 2019 Blindness Detection dataset, an FID score of 8.8154 on the Retinal OCT Detection dataset, and an FID score of 7.4486 on the COVID CT Detection dataset.reverse engineering data. A Federated Learning paradigm of diffusion models has been proposed to overcome this hurdle and its related challenges. Our work focuses on diffusion models in federated learning settings. We named our novel model FMedDiffusion or Federated Learning on Medical Image Diffusion. We trained our model under distributed federated settings imitating real world clinical settings. We have achieved impressive results over three medical image datasets, APTOS 2019 Blindness Detection, Retinal OCT Detection, and COVID CT Detection in the federated setting on par with the traditional training. Our model FMedDiffusion has achieved an FID score of 7.1821 on the APTOS 2019 Blindness Detection dataset, an FID score of 8.8154 on the Retinal OCT Detection dataset, and an FID score of 7.4486 on the COVID CT Detection dataset.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Perumal, M., Srinivas, M.. 2025-04-23. FMed-Diffusion Federated Learning on Medical Image Diffusion. https://doi.org/10.1101/2025.04.22.649958

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗